Rehabiliation Using HUBER 360 to Reduce the Risk of Falls (HUBER-FALLS)

University of Liege

Status: Completed

Conditions: Rehabilitation; Exercise Therapy; Quality of Life; Treatment Outcome; Fall

Treatments: Device: HUBER (LPG Systems, France)

Study type: Interventional

Funder types: Other

Identifiers

NCT04687293

HUBER_CNRF01

Details and patient eligibility

About

Aim: The aim of the present study was to analyse the effects of training performed on a rotating, motorised platform (the Huber/SpineForce device from LPG Systems, Valence, France) intended to reduce the risk of falls.

Subjects: any patient 1) benefiting from a physiotherapy rehabilitation program at the CHU Liège, CNRF, Belgium; 2) presenting a pathological situation justifying functional rehabilitation with HUBER 360®; 3) presenting any pathology not constituting an exclusion criterion; 4) giving informed consent to research will be include in this 8-week interventional trial.

Design: randomized open-label trial. Patients will be randomized into the intervention group (HUBER trainig, 45 minutes of training, twice a week during 8 weeks) or in the control group (standard care).

Outcomes: the effect of the training will be measured on the Time-Up-and-Go test, on the Short-Physical performance battery test and on quality of life.

Enrollment: 32 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patient benefiting from a physiotherapy rehabilitation program at the CHU Liège, CNRF
• Patient presenting a pathological situation justifying functional rehabilitation with HUBER 360®
• Patient presenting any pathology not constituting an exclusion criterion
• Patient giving informed consent to research.

Exclusion criteria

• Cardiac or respiratory or neurological or rheumatological disease incompatible with physical activity ;
• Joint inflammation;
• Rheumatic disease in acute phase;
• Recent trauma, infection of the musculoskeletal system;
• Fever;
• Venous thrombosis ;
• Discopathy in acute phase;
• Neuropsychological problems that do not allow to integrate the instructions or other serious psychological problems;
• Cardiovascular diseases and any progressive, chronic, counter-indicative disease;
• Large anatomical deformities.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

32 participants in 2 patient groups

HUBER

Experimental group

Description:

HUBER is an isometric strengthening device. It consists of an oval motorized platform, which performs rotating, oscillatory movements with a controlled amplitude and speed. Intervention will consist of 2 sessions of HUBER per week. Each session lasts approximatively 30 minutes. The intervention is 8 weeks long.

Treatment:

Device: HUBER (LPG Systems, France)

Control

No Intervention group

Description:

The control group will not received any intervention except usual care.